US$ 22.50
glp-1 receptor agonist drugs in development research Glucagon-like peptide-1 receptor: mechanisms and advances therapy Glucagon-like peptide-1 receptor agonists and
Description
Limited head-to-head studies compare established glucagon-like peptide-1 receptor agonists (GLP-1 RAs), dipeptidyl peptidase-4 inhibitors (DPP-4is), and sodium-glucose co-transporter-2 inhibitors (SGLT-2is) to insulin in the management of uncontrolled type 2 diabetes mellitus (T2DM)

How do they work

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

GLP-1 Data Survey 2025: GLP-1 Weight Loss, Types of GLP-1 Used, GLP-1 Duration Usage, GLP-1 Side Effects, Satisfaction & more.

Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss
